University with Gender Clinic Funds Study to See if Puberty Blockers Causes ‘Lasting’ Brain Changes for Kids

The University of Wisconsin-Madison (UW) approved a $600,000 grant for a study hypothesizing that puberty blockers used on children will lead to “lasting changes” in the brain, according to documents obtained exclusively by the Daily Caller News Foundation.

In 2018, an American Academy of Pediatrics committee, which included a member of UW’s faculty, released a policy on transgender hormone treatments claiming that the effects of puberty blockers are reversible, a claim that has since been widely echoed by trans advocates. The university’s gender clinic already offers hormones to minors, but new documents obtained by the DCNF reveal that the study, which was approved for a $600,000 grant in July, hypothesizes that “short-term” transgender treatments will have “lasting changes” on the brain, internal organs and behavior.

Read More

University with Gender Clinic Funds Study to See if Puberty Blockers Causes ‘Lasting’ Brain Changes for Kids

The University of Wisconsin-Madison (UW) approved a $600,000 grant for a study hypothesizing that puberty blockers used on children will lead to “lasting changes” in the brain, according to documents obtained exclusively by the Daily Caller News Foundation.

In 2018, an American Academy of Pediatrics committee, which included a member of UW’s faculty, released a policy on transgender hormone treatments claiming that the effects of puberty blockers are reversible, a claim that has since been widely echoed by trans advocates. The university’s gender clinic already offers hormones to minors, but new documents obtained by the DCNF reveal that the study, which was approved for a $600,000 grant in July, hypothesizes that “short-term” transgender treatments will have “lasting changes” on the brain, internal organs and behavior.

Read More

Doctor Asked for Grant to Study Trans Hormones on Rats, Admits ‘Severe Lack’ of Research, Emails Show

Dr. Walid Farhat, a professor of Urology at the University of Wisconsin-Madison, applied in April for a grant to study the impact of cross-sex hormones and puberty blockers on prepubescent rats, acknowledging the research on the potential side effects is “severely lacking,” according to emails obtained through a Daily Caller News Foundation Freedom of Information Act request.

Farhat, who is also chief of the division of Pediatric Urology at the UW’s School of Medicine and Public Health, applied to the Wisconsin Partnership Program (WPP) for a research grant to study the potential side effects of cross-sex hormones and puberty blockers on “prepubertal male and female” rats into adulthood, according to an April email. The application claimed that the study would help close the gap in research on minors receiving transgender hormone therapy, which Farhat maintained was “relatively safe,” and criticized the attempts to withhold access to the medication.

Read More